Head to Head Analysis: Bioceres Crop Solutions (BIOX) vs. Its Competitors

Bioceres Crop Solutions (NASDAQ:BIOXGet Free Report) is one of 17 publicly-traded companies in the “Agricultural chemicals” industry, but how does it contrast to its peers? We will compare Bioceres Crop Solutions to related companies based on the strength of its risk, profitability, valuation, dividends, earnings, analyst recommendations and institutional ownership.

Valuation & Earnings

This table compares Bioceres Crop Solutions and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bioceres Crop Solutions $334.80 million -$7.20 million 56.30
Bioceres Crop Solutions Competitors $4.87 billion $910.98 million 5.52

Bioceres Crop Solutions’ peers have higher revenue and earnings than Bioceres Crop Solutions. Bioceres Crop Solutions is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

13.4% of Bioceres Crop Solutions shares are owned by institutional investors. Comparatively, 40.7% of shares of all “Agricultural chemicals” companies are owned by institutional investors. 2.3% of Bioceres Crop Solutions shares are owned by insiders. Comparatively, 9.7% of shares of all “Agricultural chemicals” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Bioceres Crop Solutions and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bioceres Crop Solutions 3.56% 5.37% 1.98%
Bioceres Crop Solutions Competitors -1,025.19% -21.52% -22.15%

Analyst Ratings

This is a breakdown of recent ratings for Bioceres Crop Solutions and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioceres Crop Solutions 0 0 3 0 3.00
Bioceres Crop Solutions Competitors 213 505 532 62 2.34

Bioceres Crop Solutions presently has a consensus price target of $25.33, indicating a potential upside of 124.99%. As a group, “Agricultural chemicals” companies have a potential upside of 25.79%. Given Bioceres Crop Solutions’ stronger consensus rating and higher possible upside, equities analysts plainly believe Bioceres Crop Solutions is more favorable than its peers.

Volatility and Risk

Bioceres Crop Solutions has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Bioceres Crop Solutions’ peers have a beta of 1.16, meaning that their average stock price is 16% more volatile than the S&P 500.

Summary

Bioceres Crop Solutions beats its peers on 7 of the 13 factors compared.

Bioceres Crop Solutions Company Profile

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Bolivia, Brazil, the United States, Paraguay, South Africa, France, Uruguay, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina.

Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.